Information Provided By: 
Fly News Breaks for July 12, 2019
ILMN
Jul 12, 2019 | 06:34 EDT
Barclays analyst Jack Meehan calls the magnitude of Illumina's Q2 miss "very disappointing" but keeps an Overweight rating on the shares. He lowered his price target for the stock to $340 from $370. Given underlying funding and the transitory nature of the Q2 issues, the new guidance could prove conservative, Meehan tells investors in a research note.
News For ILMN From the Last 2 Days
There are no results for your query ILMN
